Clinical Trial Update: A Study of NX-1607 in Adults With Advanced Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating NX-1607 in adults with advanced malignancies is actively recruiting across multiple tumor types, including ovarian epithelial cancer,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Gastric Cancer
• Gastroesophageal Junction Cancer
• Head and Neck Squamous Cell Carcinoma
• Malignant Pleural Mesothelioma
• Melanoma
• Non-small Cell Lung Cancer
• Ovarian Epithelial Cancer

Drugs mentioned

• NX-1607

Snippet

Sponsor: Nurix Therapeutics, Inc. | Conditions: Ovarian Cancer, Epithelial, Gastric Cancer | Phase 1 | Status: RECRUITING